May 5, 202611 min read
Types of Family Therapy Explained
Learn about the main types of family therapy, how each approach works, and how therapy can help families build stronger relationships.
MaveirckRead
Same-day assessments · Orange County, CA
Same-day assessments · Orange County, CA
Kratom Side Effects: Understanding Risks, Withdrawal Symptoms, and Treatment Options Kratom side effects have emerged as a pressing concern for the estimated 2.1 million Americans who used this herbal supplement in 2020, with impacts ranging from nausea and high blood pressure to emotional disturban
Jake
Clinical Editorial Team
Kratom Side Effects: Understanding Risks, Withdrawal Symptoms, and Treatment Options Kratom side effects have emerged as a pressing concern for the estimated 2.1 million Americans who used this herbal supplement in 2020, with impacts ranging from nausea and high blood pressure to emotional disturban
Kratom side effects have emerged as a pressing concern for the estimated 2.1 million Americans who used this herbal supplement in 2020, with impacts ranging from nausea and high blood pressure to emotional disturbances and dependence. By exploring common physical and mental health reactions, recognizing signs of addiction and withdrawal, and examining evidence-based treatment options—including those offered by RizeOC—readers can make informed decisions and seek timely care. This article will cover:
Learn about the main types of family therapy, how each approach works, and how therapy can help families build stronger relationships.
Explore how family therapy for addiction recovery helps loved ones rebuild trust, improve support, and create a healthier path forward.
Take the Next Step
If you or a loved one is struggling with addiction or mental health, the Rize OC team is here to help — confidentially and with no obligation.
Common physical side effects of kratom—such as nausea, constipation, and dry mouth—result from its alkaloids interacting with gastrointestinal and opioid receptors, and recognizing these reactions early can guide effective symptom management. Kratom’s mitragynine and 7-hydroxymitragynine compounds produce both stimulant and sedative effects that alter gut motility, cardiovascular function, and neurological signaling, highlighting the importance of dose awareness.
Mild to moderate reactions often appear shortly after consumption and can be managed with supportive care.
These gastrointestinal disturbances frequently resolve with hydration and dietary adjustments, preparing us to consider more severe organ-related risks.
Kratom use can lead to hepatotoxicity and cardiovascular strain when high doses overload metabolic pathways. Liver injury arises from reactive metabolites of alkaloids accumulating in hepatocytes, while tachycardia and hypertension develop as kratom stimulates adrenergic receptors. Monitoring liver enzymes and blood pressure is essential to detect early organ stress and prevent long-term damage.
This case series highlights that kratom use can lead to drug-induced liver injury (DILI), with symptoms such as jaundice, itching, abdominal pain, or fever. It notes that liver injury typically occurs within 2 to 6 weeks of use and emphasizes the importance of considering kratom as a potential cause of hepatic dysfunction.
This citation provides evidence for the article’s claims regarding serious health risks to the liver, specifically hepatotoxicity, and the clinical presentation of such injuries.
High or prolonged kratom consumption can trigger neurological events—including seizures, tremors, and confusion—when alkaloids disrupt neurotransmitter homeostasis in the central nervous system. These effects stem from mitragynine’s partial agonist action at μ-opioid receptors and NMDA modulation, underscoring the need for medical evaluation if neurological signs emerge.
Beyond core reactions, kratom can influence metabolism and skin health.
These secondary effects reinforce the complex physiological footprint of kratom and lead us to examine its mental health consequences.
This comprehensive review identifies tachycardia and hypertension as the most common acute adverse cardiovascular effects of kratom. It also discusses that mitragynine, a primary alkaloid, can induce prolonged QTc intervals and potentially increase the risk of ventricular arrhythmia, especially when co-administered with other substances.
This research supports the article’s discussion on how kratom can lead to cardiovascular strain, including tachycardia, hypertension, and other potential cardiac toxicities.
Kratom’s psychoactive alkaloids alter serotonin and dopamine pathways, producing mood changes that range from mild euphoria to severe anxiety, and understanding these shifts can inform safer use and timely mental health support. Chronic use may dysregulate neurotransmitter balance, increasing vulnerability to emotional disturbances and co-occurring psychiatric conditions.
This systematic review and meta-analysis explores the association between kratom use and mental health indicators. It found a small positive association with negative mental health indicators, particularly externalizing disorders, and highlights that while some users report mood enhancement, chronic use can lead to increased anxiety and irritability.
This citation provides evidence for the article’s claims about kratom’s impact on mental health and emotional well-being, including anxiety, depression, and the potential for exacerbating psychiatric conditions.
Kratom-induced mood swings often manifest as persistent anxiety—characterized by racing thoughts, restlessness, and panic attacks—and depressive episodes marked by low mood, lack of interest, and fatigue. These affective fluctuations result from repeated receptor overstimulation and can worsen when tolerance leads to escalating doses.
Yes, high concentrations of kratom alkaloids can provoke psychosis and hallucinations through excessive NMDA receptor modulation and dopamine surge. Users may experience vivid visual distortions, paranoia, or delusional thinking, particularly when combining kratom with other psychoactive substances.
Kratom’s dual stimulant-sedative profile can disrupt circadian rhythms and provoke irritability. At lower doses, stimulant effects cause insomnia and racing thoughts; at higher doses, sedative properties may induce excessive sleepiness and grogginess, leading to daytime fatigue and mood disturbances.
Individuals with pre-existing anxiety, depression, or trauma histories face higher risks of self-medicating with kratom, which can mask symptoms but ultimately exacerbate underlying disorders. This bidirectional relationship underscores the need for integrated treatment approaches that address both substance use and mental health.
Kratom addiction develops when repeated use creates tolerance and cravings, prompting compulsive intake despite harm. Recognizing early dependence and behavioral changes is crucial for timely intervention and recovery planning.
Physical and psychological dependence can be identified by observable patterns.
Spotting these signs allows for an informed discussion about professional support.
This comprehensive review details how kratom’s psychoactive alkaloids, mitragynine and 7-hydroxymitragynine, act as partial mu-opioid agonists, leading to dependence and withdrawal symptoms. It outlines both psychological (depressed mood, anxiety, irritability) and physical (myalgia, joint pain, insomnia, diarrhea) withdrawal symptoms, and discusses effective treatment options, including sublingual buprenorphine-naloxone.
This research directly supports the article’s sections on the mechanisms of kratom dependence, the range of withdrawal symptoms experienced, and the efficacy of medication-assisted treatments like buprenorphine-naloxone.
Compulsive use despite negative consequences—such as declining work performance, social withdrawal, and unsuccessful quit attempts—signals a use disorder. Cravings drive continued consumption even when experiencing adverse side effects, reflecting a loss of control characteristic of addiction.
Prolonged use fosters chronic tolerance development, leading to higher dose requirements and greater potential for polysubstance interactions. Habitual consumption rewires reward circuits in the brain, heightening vulnerability to relapse and complicating recovery efforts.
Acute kratom withdrawal emerges within 8–24 hours after the last dose, peaking around day 2–3 and gradually subsiding over 5–14 days, while post-acute withdrawal symptoms may linger for weeks. Understanding this timeline helps users anticipate challenges and plan supportive care.
The onset of withdrawal brings both physical and psychological distress.
These symptoms typically peak by day 2 and gradually ease, guiding symptom-focused relief strategies.
Acute withdrawal usually resolves within two weeks, but individual factors—such as dose, duration, and metabolic rate—can extend this phase. A tapering approach under medical supervision often mitigates severity and shortens overall duration.
PAWS encompasses lingering emotional and cognitive symptoms—such as mood swings, insomnia, and concentration difficulties—that persist weeks to months after acute withdrawal. These protracted effects reflect ongoing neurochemical recalibration and require structured psychosocial support.
Effective management combines medical oversight with holistic strategies:
Addressing both physical discomfort and emotional distress paves the way to stable recovery.
Evidence-based treatment for kratom addiction includes structured detoxification, therapy modalities, medication-assisted treatment (MAT), and a choice between virtual and in-person programs to suit individual needs. At RizeOC, personalized virtual programs enhance accessibility for working professionals and families.
Medical detoxification provides safe, supervised withdrawal, managing acute symptoms with tailored pharmacological and non-pharmacological interventions. This structured environment reduces risk of complications and prepares individuals for ongoing therapy.
Therapeutic approaches integrate evidence-based methods:
These modalities build coping skills and resilience against relapse.
MAT combines FDA-approved medications—such as buprenorphine or naltrexone—with counseling to reduce cravings, stabilize neurochemistry, and support sustained abstinence. This dual approach addresses both physiological dependence and psychological factors.
Virtual programs offer flexible scheduling, privacy, and continuous access to licensed professionals, making recovery compatible with daily responsibilities. Real-time teletherapy and online support groups maintain accountability and reduce barriers to care.
Program Type
Setting
Suitable For
Inpatient
Residential facility with 24/7 support
Individuals requiring intensive monitoring
Outpatient
Daytime treatment with home living
Those with stable environments and obligations
Kratom remains unapproved by the FDA and designated a “drug of concern” by the DEA, reflecting ongoing debates over safety and legality. Staying informed about evolving regulations safeguards access to treatment and harm-reduction resources.
The FDA has cautioned against kratom use due to risks of liver toxicity, seizures, and substance use disorder, urging consumers to avoid unregulated products. These advisories highlight documented cases of adverse events and emphasize the absence of approved medical indications.
The DEA classifies kratom as a “drug of concern” based on its psychoactive properties and potential for dependence, although it remains unscheduled federally. This status informs law enforcement and public health strategies aimed at monitoring misuse.
Several states and municipalities have enacted bans or age restrictions on kratom sales, creating a patchwork legal landscape. Users must verify local statutes to ensure compliance and maintain uninterrupted access to licensed treatment programs.
Shifts in federal or state policy can influence product quality, availability of harm-reduction services, and insurance coverage for treatment. Staying current with regulatory developments enables proactive planning and uninterrupted recovery support.
Early intervention maximizes recovery outcomes by leveraging structured treatment before complications escalate. Recognizing clear indicators and involving family resources fosters a supportive environment conducive to healing.
Several signs warrant professional evaluation:
Family involvement can include compassionate communication, assisting with appointment coordination, and participating in education sessions. Providing emotional support and helping monitor physical and behavioral changes strengthens the recovery network.
Initiating care involves a confidential assessment to determine the appropriate level of support, followed by personalized treatment planning. RizeOC’s intake team collaborates with individuals to schedule virtual or in-person services, ensuring a seamless transition into recovery.
Kratom’s complex profile demands informed use, vigilant monitoring of physical and mental health indicators, and readiness to seek professional support when side effects or dependence arise. Evidence-based treatments—including detoxification, therapy, MAT, and virtual programs—offer clear pathways to recovery. Recognizing regulatory developments and engaging family support further bolsters success, empowering individuals to reclaim control and achieve lasting wellness.
Kratom’s legal status varies across the United States. While it remains unscheduled at the federal level, several states and municipalities have enacted bans or restrictions on its sale and use. The DEA classifies kratom as a “drug of concern,” which reflects ongoing debates about its safety and potential for abuse. Users should check local laws to ensure compliance and understand the implications for access to kratom and related treatment options.
Long-term kratom use can lead to several adverse effects, including the development of tolerance, dependence, and withdrawal symptoms. Chronic users may experience persistent gastrointestinal issues, mood disturbances, and cognitive impairments. Additionally, prolonged use can increase the risk of cardiovascular problems and liver damage. It is essential for users to monitor their health and seek medical advice if they notice any concerning symptoms or changes in their well-being.
Discontinuing kratom should ideally be done under medical supervision to manage withdrawal symptoms effectively. A gradual tapering approach is recommended, where the dosage is slowly reduced over time to minimize discomfort. Supportive care, including hydration, nutrition, and counseling, can also aid in the process. Engaging in behavioral therapies and support groups can provide additional emotional and psychological support during the transition away from kratom.
Kratom can interact with various substances, including prescription medications, alcohol, and other recreational drugs. These interactions can amplify side effects or lead to dangerous health complications, such as respiratory depression or increased heart rate. Users should consult healthcare professionals before combining kratom with any other substances to ensure safety and avoid adverse reactions.
Hydration is crucial in managing kratom side effects, particularly gastrointestinal issues like constipation and nausea. Adequate fluid intake can help alleviate these symptoms and support overall bodily functions. Additionally, staying hydrated can assist in the detoxification process during withdrawal, making it easier for the body to adjust and recover. Users should prioritize drinking water and electrolyte-rich fluids to maintain optimal hydration levels.
Family members can play a vital role in supporting someone struggling with kratom use by fostering open communication and understanding. They can help by encouraging the individual to seek professional help, attending therapy sessions together, and providing emotional support. Additionally, family members can assist in monitoring the person’s health and behavior, helping to identify any concerning changes that may require intervention.
Immediate medical attention is warranted if an individual experiences severe symptoms such as chest pain, difficulty breathing, seizures, or signs of liver damage (e.g., jaundice, severe abdominal pain). Additionally, if someone exhibits severe psychological symptoms like hallucinations, extreme agitation, or suicidal thoughts, it is crucial to seek emergency help. Recognizing these signs early can prevent serious health complications and facilitate timely intervention.
Kratom’s multifaceted effects necessitate a thorough understanding of its risks and the importance of seeking professional help for side effects and addiction. By recognizing the signs of dependence and utilizing evidence-based treatment options, individuals can navigate their recovery journey effectively. Engaging with supportive resources, such as RizeOC, enhances the likelihood of achieving lasting wellness. Take the first step towards recovery today by exploring our personalized treatment programs.
About the Author
In This Article
Ready for Help?
Confidential support, same day.
